B Cell News and Research

RSS
Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Treg cell Notch receptors drive SARS-CoV-2-induced MIS-C

Treg cell Notch receptors drive SARS-CoV-2-induced MIS-C

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

SARS-CoV-2 mutations change proteasome processing to alter CD8+ T cell responses

SARS-CoV-2 mutations change proteasome processing to alter CD8+ T cell responses

The human antibody response to the SARS-CoV-2 spike protein N-terminal domain in a group of previously infected individuals

The human antibody response to the SARS-CoV-2 spike protein N-terminal domain in a group of previously infected individuals

Immunocompromised hosts with Delta/Omicron co-infections

Immunocompromised hosts with Delta/Omicron co-infections

Neutralization potency against the Omicron variant of naturally expressed MBC-derived IgG antibodies from vaccinated individuals

Neutralization potency against the Omicron variant of naturally expressed MBC-derived IgG antibodies from vaccinated individuals

Developing and manufacturing custom recombinant antibodies for R&D

Developing and manufacturing custom recombinant antibodies for R&D

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

Key protein could be a novel target for treatment of patients with B cell signaling deficiencies

Key protein could be a novel target for treatment of patients with B cell signaling deficiencies

Research illuminates why immune disorders affect only one of two identical twins

Research illuminates why immune disorders affect only one of two identical twins

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

New antidiabetic substance preserves the activity of beta cells, prevents high blood glucose in mice

New antidiabetic substance preserves the activity of beta cells, prevents high blood glucose in mice

Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Tuberculosis infection protects mice against COVID-19

Tuberculosis infection protects mice against COVID-19